Publicacións nas que colabora con Enrique Aranda Aguilar (52)

2023

  1. Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials

    Clinical Colorectal Cancer, Vol. 22, Núm. 2, pp. 222-230

2021

  1. Early clinical experience with trifluridine/tipiracil for refractory metastatic colorectal cancer: The ros study

    Cancers, Vol. 13, Núm. 18

  2. Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and Implications

    JCO oncology practice, Vol. 17, Núm. 8, pp. e1162-e1169

2019

  1. Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer (Scientific Reports, (2019), 9, 1, (2589), 10.1038/s41598-019-39291-2)

    Scientific Reports

  2. Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: An expert taskforce review

    Annals of Oncology, Vol. 28, Núm. 12, pp. 2943-2949

2012

  1. Kisspeptins and reproduction: Physiological roles and regulatory mechanisms

    Physiological Reviews, Vol. 92, Núm. 3, pp. 1235-1316

2011

  1. Consenso de la Sociedad Española de Anatomía Patológica (SEAP) y de la Sociedad Española de Oncología Médica (SEOM) sobre la determinación de HER2 en el carcinoma gástrico

    Revista Espanola de Patologia, Vol. 44, Núm. 1, pp. 32-48

  2. Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma

    Clinical and Translational Oncology, Vol. 13, Núm. 9, pp. 636-651

  3. Early metabolic programming of puberty onset: Impact of changes in postnatal feeding and rearing conditions on the timing of puberty and development of the hypothalamic kisspeptin system

    Endocrinology, Vol. 152, Núm. 9, pp. 3396-3408

2010

  1. The anorexigenic neuropeptide, nesfatin-1, is indispensable for normal puberty onset in the female rat

    Journal of Neuroscience, Vol. 30, Núm. 23, pp. 7783-7792

2009

  1. Alterations in hypothalamic kiSS-1 system in experimental diabetes: Early changes and functional consequences

    Endocrinology, Vol. 150, Núm. 2, pp. 784-794

  2. KiSS-1/kisspeptins and the metabolic control of reproduction: Physiologic roles and putative physiopathological implications

    Peptides, Vol. 30, Núm. 1, pp. 139-145

  3. The mammalian target of rapamycin as novel central regulator of puberty onset via modulation of hypothalamic Kiss1 system

    Endocrinology, Vol. 150, Núm. 11, pp. 5016-5026

2008

  1. Desensitization of gonadotropin responses to kisspeptin in the female rat: Analyses of LH and FSH secretion at different developmental and metabolic states

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 294, Núm. 6

  2. New frontiers in kisspeptin/GPR54 physiology as fundamental gatekeepers of reproductive function

    Frontiers in Neuroendocrinology, Vol. 29, Núm. 1, pp. 48-69

2007

  1. Neuromedin S as novel putative regulator of luteinizing hormone secretion

    Endocrinology, Vol. 148, Núm. 2, pp. 813-823

2006

  1. Comparative analysis of the effects of ghrelin and unacylated ghrelin on luteinizing hormone secretion in male rats

    Endocrinology, Vol. 147, Núm. 5, pp. 2374-2382

  2. Effects of single or repeated intravenous administration of kisspeptin upon dynamic LH secretion in conscious male rats

    Endocrinology, Vol. 147, Núm. 6, pp. 2696-2704

  3. Expression of KiSS-1 in rat ovary: Putative local regulator of ovulation?

    Endocrinology, Vol. 147, Núm. 10, pp. 4852-4862